“DEVELOPMENT OF AN IMPROVED EPSTEIN-BARR VIRUS (EBV) NEUTRALIZING ANTIBODY ASSAY TO FACILITATE DEVELOPMENT OF A PROPHYLACTIC GP350-SUBUNIT EBV VACCINE”, Mediterr J Hematol Infect Dis, vol. 12, no. 1, p. e2020016, Feb. 2020, doi: 10.4084/mjhid.2020.016.